Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion

MRI ‐based deep learning techniques for the prediction of isocitrate dehydrogenase and 1p/19q status in grade 2–4 adult gliomas

(2023) Dinusha Kalaroopan et al.   Journal of Medical Imaging and Radiation Oncology

Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas

(2023) Arian Lasocki et al.   NEURORADIOLOGY

The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis

(2021) Sang Ik Park et al.   EUROPEAN RADIOLOGY

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: a comprehensive meta‐analysis based on a Cochrane Systematic Review

(2021) Sebastian Brandner et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Neuro-Oncology and Radiogenomics: Time to Integrate?

(2020) A. Lasocki et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review

(2020) Arian Lasocki et al.   NEURORADIOLOGY

Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review

(2020) A.P. Bhandari et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status

(2019) Harpreet Hyare et al.   EUROPEAN JOURNAL OF RADIOLOGY

MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization

(2019) Sohil H. Patel et al.   RADIOLOGY

MRI Features Can Predict 1p/19q Status in Intracranial Gliomas

(2018) A. Lasocki et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis

(2018) S. C. Thust et al.   EUROPEAN RADIOLOGY

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study

(2018) Martinus P G Broen et al.   NEURO-ONCOLOGY

IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas

(2017) Amélie Darlix et al.   JOURNAL OF NEURO-ONCOLOGY

Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status

(2017) Rachel L. Delfanti et al.   JOURNAL OF NEURO-ONCOLOGY

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas

(2016) Taiichi Saito et al.   Brain Tumor Pathology

MRI Grading versus Histology: Predicting Survival of World Health Organization Grade II-IV Astrocytomas

(2014) A. Lasocki et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma

(2014) Yong Cui et al.   JOURNAL OF NEURO-ONCOLOGY

What do we know about IDH1/2 mutations so far, and how do we use it?

(2013) Craig Horbinski   ACTA NEUROPATHOLOGICA

The Importance of 10q Status in an Outcomes-Based Comparison Between 1p/19q Fluorescence In Situ Hybridization and Polymerase Chain Reaction–Based Microsatellite Loss of Heterozygosity Analysis of Oligodendrogliomas

(2011) Craig Horbinski et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours

(2010) J. W. Kim et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses†

(2010) Artemis P. Vogazianou et al.   NEURO-ONCOLOGY